Nanobiotix SANanobiotix SANanobiotix SA

Nanobiotix SA

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪908.69 M‬EUR
‪−68.13 M‬EUR
‪−11.61 M‬EUR
‪46.77 M‬
Beta (1Y)
1.23
Employees (FY)
108
Change (1Y)
+6 +5.88%
Revenue / Employee (1Y)
‪−107.49 K‬EUR
Net income / Employee (1Y)
‪−630.85 K‬EUR

About Nanobiotix SA


CEO
Laurent Lévy
Headquarters
Paris
Founded
2003
Identifiers
2
ISINFR0011341205
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.

Check out other big names from the same industry as 5NR.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
CSEMUS.EUR
iShares MSCI EMU Small Cap UCITS ETF
Weight
0.12%
Market value
‪1.28 M‬
USD
GWX
SPDR S&P International Small Cap ETF
Weight
0.05%
Market value
‪354.89 K‬
USD
SMC
SPDR MSCI Europe Small Cap UCITS ETF (Ireland)
Weight
0.05%
Market value
‪140.29 K‬
USD
TINY
ProShares Nanotechnology ETF
Weight
2.19%
Market value
‪116.74 K‬
USD
IEUS
iShares MSCI Europe Small-Cap ETF
Weight
0.05%
Market value
‪70.48 K‬
USD
FPXE
First Trust IPOX Europe Equity Opportunities ETF
Weight
0.15%
Market value
‪7.49 K‬
USD
DBEZ
Xtrackers MSCI Eurozone Hedged Equity ETF
Weight
0.01%
Market value
‪6.56 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of 5NR is 19.90 EUR — it has increased by 5.18% in the past 24 hours. Watch Nanobiotix SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Nanobiotix SA stocks are traded under the ticker 5NR.
5NR stock has risen by 5.29% compared to the previous week, the month change is a 13.15% rise, over the last year Nanobiotix SA has showed a 537.82% increase.
We've gathered analysts' opinions on Nanobiotix SA future price: according to them, 5NR price has a max estimate of 28.00 EUR and a min estimate of 3.33 EUR. Watch 5NR chart and read a more detailed Nanobiotix SA stock forecast: see what analysts think of Nanobiotix SA and suggest that you do with its stocks.
5NR reached its all-time high on Oct 9, 2025 with the price of 26.45 EUR, and its all-time low was 1.68 EUR and was reached on May 4, 2023. View more price dynamics on 5NR chart.
See other stocks reaching their highest and lowest prices.
5NR stock is 6.17% volatile and has beta coefficient of 1.23. Track Nanobiotix SA stock price on the chart and check out the list of the most volatile stocks — is Nanobiotix SA there?
Today Nanobiotix SA has the market capitalization of ‪948.23 M‬, it has decreased by −2.99% over the last week.
Yes, you can track Nanobiotix SA financials in yearly and quarterly reports right on TradingView.
Nanobiotix SA is going to release the next earnings report on Apr 28, 2026. Keep track of upcoming events with our Earnings Calendar.
5NR earnings for the last half-year are −0.11 EUR per share, whereas the estimation was −0.21 EUR, resulting in a 47.62% surprise. The estimated earnings for the next half-year are 0.01 EUR per share. See more details about Nanobiotix SA earnings.
Nanobiotix SA revenue for the last half-year amounts to ‪26.60 M‬ EUR, despite the estimated figure of ‪20.35 M‬ EUR. In the next half-year revenue is expected to reach ‪25.40 M‬ EUR.
5NR net income for the last half-year is ‪−5.38 M‬ EUR, while the previous report showed ‪−21.87 M‬ EUR of net income which accounts for 75.39% change. Track more Nanobiotix SA financial stats to get the full picture.
No, 5NR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 24, 2025, the company has 108 employees. See our rating of the largest employees — is Nanobiotix SA on this list?
Like other stocks, 5NR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nanobiotix SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nanobiotix SA technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nanobiotix SA stock shows the buy signal. See more of Nanobiotix SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.